Glynn Wilson

Glynn Wilson has been in the business world since 1996, when they were the President of GW Group. From 2007 to 2011, they were the Chairman and CEO of TapImmune Inc. Glynn then moved on to become Chairman and President of Deodora Pharma from 2011 to 2019. In 2019, they were President of St John's Technology, and they are currently the Chairman and Head of R&D for Jupiter Wellness, Inc.

Glynn Wilson received a Ph.D. in Biochemistry from Heriot-Watt University between 1969 and 1972.